Article
AJMC® in the Press, October 14, 2022
Author(s):
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by CBS News cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article indicated that Teva, the largest US supplier of amphetamine/dextroamphetamine (Adderall), expects shortages of the drug to persist for the next 2 to 3 months.
Becker’s Hospital Review featured an article discussing the findings of a study published in the September 2022 issue of AJMC®. The study, “Physician Response to COVID-19–Driven Telehealth Flexibility for Opioid Use Disorder,” found that most physicians want to continue using telehealth to treat opioid use disorder after the pandemic ends. The results were also highlighted by the Yale School of Medicine.
News24 cited a video interview published on AJMC.com. The video interview with Rona Z. Silkiss, MD, FACS, an oculoplastic surgeon and owner of Silkiss Eye Surgery, reviewed the use of biologics to treat thyroid eye disease.
Expert Insights on How Utilization Management Drives Physician Burnout
